following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
the report called this “one of the most significant perils to humans resulting from human activity.”. november 2012 (20). january 2016 (24). all programs .